Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Page

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1991
Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndromeK DeSchryver-Kecskemeti, T L Gramlich, L J Crofford, et al.
The Journal of Small Animal Practice|June 21, 2023
Quality of amoxicillin/clavulanic acid oral formulations for intended veterinary use in the UK, Malaysia, Serbia and ThailandL Pelligand, D Baker, A Sivagurunathan, et al.
The Journal of Rheumatology|December 1, 1994
An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophanD Michelson, S W Page, R Casey, et al.
Neuroimmunomodulation|January 1, 1994
1,1'-Ethylidenebis[L-tryptophan], a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome, suppresses mRNA expression of hypothalamic corticotropin-releasing hormone in Lewis (LEW/N) rat brainL S Brady, S W Page, F S Thomas, et al.
The Journal of Clinical Investigation|November 1, 1990
L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis ratL J Crofford, J I Rader, M C Dalakas, et al.
The Journal of Clinical Investigation|March 1, 1993
Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis ratsL A Love, J I Rader, L J Crofford, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1991
Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndromeK DeSchryver-Kecskemeti, T L Gramlich, L J Crofford, et al.
The Journal of Small Animal Practice|June 21, 2023
Quality of amoxicillin/clavulanic acid oral formulations for intended veterinary use in the UK, Malaysia, Serbia and ThailandL Pelligand, D Baker, A Sivagurunathan, et al.
The Journal of Rheumatology|December 1, 1994
An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophanD Michelson, S W Page, R Casey, et al.
Neuroimmunomodulation|January 1, 1994
1,1'-Ethylidenebis[L-tryptophan], a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome, suppresses mRNA expression of hypothalamic corticotropin-releasing hormone in Lewis (LEW/N) rat brainL S Brady, S W Page, F S Thomas, et al.
The Journal of Clinical Investigation|November 1, 1990
L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis ratL J Crofford, J I Rader, M C Dalakas, et al.
The Journal of Clinical Investigation|March 1, 1993
Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis ratsL A Love, J I Rader, L J Crofford, et al.
Pageof 6